Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging

Autor: Dow-Mu Koh, Masatoshi Kudo, M. Isabel Fiel, Nikolaos Kartalis, Cher Heng Tan, Sheng Hong Ju, Ghaneh Fananapazir, Ahmed Ba-Ssalamah, Jin Wang, Takamichi Murakami, Jeong Min Lee, Jeong Hee Yoon, Bachir Taouli, Jian Zhou, Max Seidensticker, Claude B. Sirlin, Giuseppe Brancatelli, Mengsu Zeng, Satoshi Goshima
Přispěvatelé: Koh, Dow-Mu, Ba-Ssalamah, Ahmed, Brancatelli, Giuseppe, Fananapazir, Ghaneh, Fiel, M Isabel, Goshima, Satoshi, Ju, Sheng-Hong, Kartalis, Nikolao, Kudo, Masatoshi, Lee, Jeong Min, Murakami, Takamichi, Seidensticker, Max, Sirlin, Claude B, Tan, Cher Heng, Wang, Jin, Yoon, Jeong Hee, Zeng, Mengsu, Zhou, Jian, Taouli, Bachir
Rok vydání: 2021
Předmět:
Gadolinium DTPA
Magnetic Resonance Spectroscopy
Hepatocellular carcinoma
Gadoxetic acid
Contrast Media
Oral and gastrointestinal
030218 nuclear medicine & medical imaging
Liver disease
0302 clinical medicine
Cancer
Neuroradiology
medicine.diagnostic_test
Liver Disease
Liver Neoplasms
Interventional radiology
General Medicine
Metastatic liver disease
Nuclear Medicine & Medical Imaging
030220 oncology & carcinogenesis
Biomedical Imaging
Radiology
medicine.symptom
Primary liver cancer
After treatment
medicine.drug
Liver Cancer
medicine.medical_specialty
Carcinoma
Hepatocellular
Consensus
Chronic Liver Disease and Cirrhosis
Clinical Sciences
Sensitivity and Specificity
03 medical and health sciences
Magnetic resonance imaging
Rare Diseases
medicine
Humans
Radiology
Nuclear Medicine and imaging
Retrospective Studies
business.industry
Carcinoma
Hepatocellular
medicine.disease
Orphan Drug
Digestive Diseases
business
Zdroj: European radiology, vol 31, iss 8
ISSN: 1432-1084
0938-7994
DOI: 10.1007/s00330-020-07637-4
Popis: Objectives The 9th International Forum for Liver Magnetic Resonance Imaging (MRI) was held in Singapore in September 2019, bringing together radiologists and allied specialists to discuss the latest developments in and formulate consensus statements for liver MRI, including the applications of gadoxetic acid–enhanced imaging. Methods As at previous Liver Forums, the meeting was held over 2 days. Presentations by the faculty on days 1 and 2 and breakout group discussions on day 1 were followed by delegate voting on consensus statements presented on day 2. Presentations and discussions centered on two main meeting themes relating to the use of gadoxetic acid–enhanced MRI in primary liver cancer and metastatic liver disease. Results and conclusions Gadoxetic acid–enhanced MRI offers the ability to monitor response to systemic therapy and to assist in pre-surgical/pre-interventional planning in liver metastases. In hepatocellular carcinoma, gadoxetic acid–enhanced MRI provides precise staging information for accurate treatment decision-making and follow-up post therapy. Gadoxetic acid–enhanced MRI also has potential, currently investigational, indications for the functional assessment of the liver and the biliary system. Additional voting sessions at the Liver Forum debated the role of multidisciplinary care in the management of patients with liver disease, evidence to support the use of abbreviated imaging protocols, and the importance of standardizing nomenclature in international guidelines in order to increase the sharing of scientific data and improve the communication between centers. Key Points • Gadoxetic acid–enhanced MRI is the preferred imaging method for pre-surgical or pre-interventional planning for liver metastases after systemic therapy. • Gadoxetic acid–enhanced MRI provides accurate staging of HCC before and after treatment with locoregional/biologic therapies. • Abbreviated protocols for gadoxetic acid–enhanced MRI offer potential time and cost savings, but more evidence is necessary. The use of gadoxetic acid–enhanced MRI for the assessment of liver and biliary function is under active investigation.
Databáze: OpenAIRE
Externí odkaz: